TB-500 (Thymosin Beta-4): Systemic Anti-Inflammatory Reach TB-500 is the synthetic analogue of thymosin beta-4, a naturally occurring 43-amino-acid protein involved in cell migration, tissue repair, and inflammatory regulation
In phase II trials focusing on dermal applications, TB-500 has displayed promising outcomes for patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa
Phase 2B results for AOD9604 do not support commercial viability (obesity indication)
That means four 20mg vials just to reach your maintenance dose
Before introducing a B12 supplement to your routine, first determine if your body truly requires it through a blood test and conversation with your doctor
Subcutaneous administration (which bypasses first-pass metabolism and delivers more peptide to target tissues) was not extensively tested in human trials, and this route is what most current research protocols use